Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions

Author:

Boekestijn Bas,Feshtali Shirin,Vasen Hans,van Leerdam Monique E.,Bonsing Bert A.,Mieog J. Sven D.,Wasser Martin N.

Abstract

AbstractPancreatic cancer has a dismal prognosis in the general population. However, early detection and treatment of disease in high-risk individuals can improve survival, as patients with localized disease and especially patients with lesions smaller than 10 mm show greatly improved 5-year survival rates. To achieve early detection through MRI surveillance programs, optimization of imaging is required. Advances in MRI technologies in both hardware and software over the years have enabled reliable detection of pancreatic cancer at a small size and early stage. Standardization of dedicated imaging protocols for the pancreas are still lacking. In this review we discuss state of the art scan techniques, sequences, reduction of artifacts and imaging strategies that enable early detection of lesions. Furthermore, we present the imaging features of small pancreatic cancers from a large cohort of high-risk individuals. Refinement of MRI techniques, increased scan quality and the use of artificial intelligence may further improve early detection and the prognosis of pancreatic cancer in a screening setting.

Publisher

Springer Science and Business Media LLC

Reference49 articles.

1. Cancer of the Pancreas - Cancer Stat Facts. In: SEER. https://seer.cancer.gov/statfacts/html/pancreas.html. Accessed 26 Jul 2023

2. Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthäi E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T, Bonsing BA, de Cappel VTN, Bergman WH, Wasser W, Morreau M, Klöppel H, Schicker G, Steinkamp C, Figiel M, Esposito J, Mocci I, Vazquez-Sequeiros E, Sanjuanbenito E, Muñoz-Beltran A, Montans M, Langer J, Fendrich P, Bartsch V DK (2016) Benefit of Surveillance for Pancreatic Cancer in High-Risk individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert centers. J Clin Oncol Off J Am Soc Clin Oncol 34:2010–2019. https://doi.org/10.1200/JCO.2015.64.0730

3. Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M (2018) Risk of neoplastic progression in individuals at high risk for pancreatic Cancer Undergoing Long-Term Surveillance. Gastroenterology 155:740–751e2. https://doi.org/10.1053/j.gastro.2018.05.035

4. Klatte DCF, Boekestijn B, Wasser MNJM, Feshtali Shahbazi S, Ibrahim IS, Mieog JSD, Luelmo SAC, Morreau H, Potjer TP, Inderson A, Boonstra JJ, Dekker FW, Vasen HFA, van Hooft JE, Bonsing BA, van Leerdam ME (2022) Pancreatic Cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-Year prospective Follow-Up. J Clin Oncol 40:3267–3277. https://doi.org/10.1200/JCO.22.00194

5. Dbouk M, Katona BW, Brand RE, Chak A, Syngal S, Farrell JJ, Kastrinos F, Stoffel EM, Blackford AL, Rustgi AK, Dudley B, Lee LS, Chhoda A, Kwon R, Ginsberg GG, Klein AP, Kamel I, Hruban RH, He J, Shin EJ, Lennon AM, Canto MI, Goggins M (2022) The Multicenter Cancer of pancreas Screening Study: Impact on Stage and Survival. J Clin Oncol 40:3257–3266. https://doi.org/10.1200/JCO.22.00298

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3